Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06607406 · ClinicalTrials.gov registry record · NA
Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
A NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma (HNSCC), sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 3
- Study locations
NCT06607406 is a NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma (HNSCC) that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 75 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT06607406, a NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma (HNSCC), is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.
Conditions Studied
Interventions
- RADIATION Accelerated radiotherapy
- RADIATION Conventional radiotherapy
Study Locations (3)
North Carolina
- Levine Cancer Institute - Charlotte
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Wisconsin
- Advocate Aurora Radiation Oncology - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2030-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06607406
The ClinicalTrials.gov registry entry for NCT06607406 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Accelerated radiotherapy is the first listed.
NCT06607406 reports 3 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06607406 about?
NCT06607406 is a clinical study titled "Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery". The goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.
What is the current status of trial NCT06607406?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-01-21. Estimated completion is 2030-01.
What conditions does trial NCT06607406 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC).
What interventions are being tested in trial NCT06607406?
The interventions under investigation include: Accelerated radiotherapy (RADIATION), Conventional radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT06607406?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06607406 being conducted?
This trial has 3 study locations across North Carolina, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
RECRUITING · NA
Explore more on PlainTrial
Head and Neck Cancer
All registered trials for this condition
Head and Neck Squamous Cell Carcinoma (HNSCC)
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.